Freenome Holdings
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Freenome Holdings sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Freenome Holdings: 5 sponsored US clinical trials, 1 recruiting.
Freenome Holdings sponsors 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 4 completed. The most-studied condition in this pipeline is Lung Cancer (Diagnosis), with 1 trials.
Upper-quartile sponsor footprint
Freenome Holdings sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
NCT06122077
The Sanderson Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening
NCT05516927
The Vallania Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening
NCT05254834
Prevention of Colorectal Cancer Through Multiomics Blood Testing
NCT04369053
AI-EMERGE: Development and Validation of a Multi-analyte, Blood-based Colorectal Cancer Screening Test
NCT03688906
Therapeutic Areas
What is open in the Freenome Holdings pipeline
1 recruiting of 5 indexed (20% open); 4 completed (80%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Lung Cancer (Diagnosis) (1 trial), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Freenome Holdings: open-pipeline peers nationwide
Peers matched on 5 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
Freenome Holdings sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Align Technology · 20% recruiting · 5 trials
- AltruBio · 20% recruiting · 5 trials
- Alvernia University · 20% recruiting · 5 trials
- Amazentis · 20% recruiting · 5 trials
Related
What to do with this Freenome Holdings page
5 registered trials is a research-attention snapshot, not an endorsement of Freenome Holdings or any single study.
- 1 of Freenome Holdings's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Lung Cancer (Diagnosis) is the condition Freenome Holdings studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Lung Cancer (Diagnosis) trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Freenome Holdings pipeline card: 5 registered trials from official public datasets.Report a data error.